Plasma somatotropin response to exogenous growth hormone releasing factor in lambs. 1987

R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh

Two experiments were performed to examine the ability of human pancreatic growth hormone releasing factor (hGRF) administration to stimulate endogenous growth hormone (GH) secretion in lambs. Each study utilized eight Dorset wether lambs in replicated 4 X 4 Latin square experiments. Growth hormone response (integrated area under the curve for 150 min post-injection) for 0, 1, 5 and 10 micrograms hGRF/kg body weight averaged 13, 23, 92 and 134 units, respectively. While the 1-microgram hGRF dose was not different (P greater than .05) than the response to saline injection, there was an increased (P less than .01) GH response to 5 or 10 micrograms hGRF. Overall the GH response increased in a log dose-response fashion. There was distinct variation between lambs in their response to hGRF. Study II examined the optimal method to administer 40 micrograms hGRF/kg body weight to maximize GH concentration over 24 h. Continuous infusion (CI) was compared with eight (8X), four (4X), or two (2X) injections/d. Hourly blood samples were obtained from all lambs. Growth hormone response (area under the curve for 24 h) was 162, 305, 306 and 220 units for CI, 8X, 4X and 2X, respectively. Growth hormone response to CI was inferior to discrete injections, and the GH response to 4X or 8X was superior to 2X/d. Results demonstrate that, in spite of lamb-to-lamb variation, one can utilize exogenous hGRF to enhance GH secretion in lambs. Thus, the ability of exogenous hGRF to enhance growth performance merits further study.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D013007 Growth Hormone-Releasing Hormone A peptide of 44 amino acids in most species that stimulates the release and synthesis of GROWTH HORMONE. GHRF (or GRF) is synthesized by neurons in the ARCUATE NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, GHRF stimulates GH release by the SOMATOTROPHS in the PITUITARY GLAND. Growth Hormone-Releasing Factor,Somatocrinin,Somatotropin-Releasing Factor 44,Somatotropin-Releasing Hormone,GHRH 1-44,GRF 1-44,Growth Hormone-Releasing Factor 44,Human Pancreatic Growth Hormone-Releasing Factor,Somatoliberin,hpGRF 44,Growth Hormone Releasing Factor,Growth Hormone Releasing Factor 44,Growth Hormone Releasing Hormone,Somatotropin Releasing Factor 44,Somatotropin Releasing Hormone

Related Publications

R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
December 1990, Journal of animal science,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
January 1984, The Journal of clinical endocrinology and metabolism,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
September 1984, JAMA,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
January 1992, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
January 1984, The Journal of clinical endocrinology and metabolism,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
January 1988, Peptides,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
December 1989, Neuroendocrinology,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
January 1988, Clinical endocrinology,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
January 1985, Minerva endocrinologica,
R S Kensinger, and L M McMunn, and R K Stover, and B R Schricker, and M L Maccecchini, and H W Harpster, and J F Kavanaugh
April 1990, Endocrinologia japonica,
Copied contents to your clipboard!